Two Cases of Interstitial Pneumonitis Caused by Rituximab Therapy

Rituximab, a chimeric monoclonal antibody directed against CD20, has become a part of the standard therapy for patients with non-Hodgkin's lymphoma either in combination with other drugs or as a single agent. The CD20 antigen is expressed on 95% of B-cell lymphoma cells and normal B-cells but,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lee, Yuna, Kyung, Sun Young, Choi, Soo Jin, Bang, Soo-Mee, Jeong, Seong Hwan, Shin, Dong Bok, Lee, Jae Hoon
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Association of Internal Medicine 2006
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3890722/
https://ncbi.nlm.nih.gov/pubmed/17017668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2006.21.3.183
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky